|
|
TERMINUS
MODIFIERS
Glen Research 5’-Modifiers are designed for use in DNA synthesizers to functionalize the 5’-terminus of the target oligonucleotide. The 5’-Amino-Modifiers are available with a variety of chain lengths to fit exactly the desired application.
The DMS(O)MT-protected amino group is easier to deprotect compared to the MMT-protected one. The sulfoxy derivative survives conditions of oligonucleotide synthesis and can either be cleaved with standard deblock solution, or left intact for HPLC purification. At the same time, the DMS(O)MT group is fully compatible with cartridge purification. When detritylation on a cartridge is carried out, the DMS(O)MT+, which is more stable than MMT+, does not reattach itself to an amine. We now offer 5’-DMS(O)MT-Amino-Modifier C6 utilizing this new trityl based protecting group.
| 10-1923-90 | 100 µmole |
50.00 |
| 10-1923-02 | 0.25g | 175.00 |
| 10-1906-90 | 100 µmole | 60.00 |
| 10-1906-02 | 0.25g | 200.00 |
| 10-1916-90 | 100 µmole | 30.00 |
| 10-1916-02 | 0.25g | 100.00 |
| 10-1912-90 | 100 µmole | 90.00 |
| 10-1912-02 | 0.25g | 300.00 |
| 10-1905-90 | 100 µmole | 60.00 |
| 10-1905-02 | 0.25g | 200.00 |
| 10-1907-90 | 100 µmole | 60.00 |
| 10-1907-02 | 0.25g | 200.00 |
The disulfide thiol modifier may be used for introducing 3’- or 5’-thiol linkages. Dithiol Phosphoramidite (DTPA) is a disulfide-containing modifier designed to functionalize synthetic DNA or RNA with multiple thiol groups and can be incorporated at any position of the oligonucleotide. Each DTPA addition leads to two thiol groups. This modifier was designed for optimal tethering of oligonucleotides to a gold surface but it can also be used for multiple reactions with maleimides and other thiol-specific derivatives. 5’-Carboxy-Modifier C10 is a unique linker designed to be added at the terminus of an oligonucleotide synthesis. It generates an activated carboxylic acid N-hydroxysuccinimide (NHS) ester suitable for immediate conjugation on the synthesis column with molecules containing a primary amine, resulting in a stable amide linkage. PC Amino-Modifier is a photocleavable C6 amino-modifier, part of our line of photocleavable (PC) modifiers.
| 10-1926-90 | 100 µmole | 60.00 |
| 10-1926-02 | 0.25g | 200.00 |
| 10-1936-90 |
100 µmole |
150.00 |
| 10-1936-02 | 0.25g | 360.00 |
| 10-1937-90 |
100 µmole |
200.00 |
| (DTPA) | 10-1937-02 | 0.25g | 480.00 |
| 10-4906-90 |
100 µmole |
135.00 |
| 10-4906-02 | 0.25g | 395.00 |
| 10-1935-90 | 100 µmole | 50.00 |
| 10-1935-02 | 0.25g | 200.00 |
|
INTELLECTUAL PROPERTY
DTPA and derived products (Chemical Products) are for
research purposes only, and may not be used for commercial, clinical,
diagnostic or any other use. These products or portions thereof are
subject to proprietary rights of FRIZ Biochem Gesellschaft für
Bioanalytik mbH. Patents Pending.
5’-Carboxy-Modifier C10 is offered for sale under
license from TriLink BioTechnologies, Inc. It is intended for research
and development purposes only, and may not be used for commercial, clinical,
diagnostic or any other use. It is covered under US Patent No. 6,320,041.
SEE ALSO
PC modifiers
p72
ABBREVIATIONS
CNEt = Cyanoethyl
CPG = Controlled Pore Glass
DMT = 4,4’-Dimethoxytrityl
Fmoc = Fluorenylmethoxycarbonyl
iPr = Isopropyl
MMT = 4-Monomethoxytrityl
T = Trityl
TFA = Trifluroacetyl
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
|
Please inquire for availability
of columns for other
instrument types.
|
SEE ALSO
SEE ALSO
|
SEQUENCE MODIFIERS
Sequence Modifiers are designed for use in automated synthesis.
The carboxy-dT is hydrolyzed during deprotection and can be coupled directly
to a molecule containing a primary amino group by a standard peptide coupling
or via the intermediate N-hydroxysuccinimide (NHS) ester. Amino-Modifier
dA, Amino-Modifier dC, Amino-Modifier dG and both Amino-Modifier dT products
can be added in place of a dA, dC, dG and dT residue, respectively, during
oligonucleotide synthesis. Corresponding Amino-Modifier supports can replace
their respective deoxynucleoside supports. After deprotection, the primary
amine on the C6 analogues is separated from the oligonucleotide by a spacer
arm with a total of 7 -10 atoms and can be labelled or attached to an
enzyme. The C2 analogue is more suitable for the attachment of molecules
designed to react with the oligonucleotide.
| 10-1089-90 | 100 µmole | 205.00 |
| 10-1089-02 | 0.25g | 455.00 |
| 10-1019-90 | 100 µmole | 225.00 |
| 10-1019-02 | 0.25g | 450.00 |
| 10-1099-95 | 50 µmole | 240.00 |
| 10-1099-90 | 100 µmole | 480.00 |
| 10-1099-02 | 0.25g | 1100.00 |
| 10-1035-90 | 100 µmole | 180.00 |
| 10-1035-02 | 0.25g | 360.00 |
| 10-1037-90 | 100 µmole | 180.00 |
| 10-1037-02 | 0.25g | 360.00 |
| 10-1037-05 | 0.5g | 720.00 |
| 10-1039-90 | 100 µmole | 180.00 |
| 10-1039-02 | 0.25g | 360.00 |
| 10-1039-05 | 0.5g | 720.00 |
| 10-1536-90 | 100 µmole | 180.00 |
| 10-1536-02 | 0.25g | 360.00 |
Our repertoire of NHS ester derivatives has been expanded to include the NHS-Carboxy-dT-CE Phosphoramidite. By making a dT analog of the Carboxy-Modifier C10, it is possible to label one or multiple sites within an oligonucleotide. This opens up the possibility to label any number of different dyes or molecules within an oligonucleotide when the phosphoramidite is unavailable. Doing so is straightforward and may be done manually off the synthesizer or even in a fully-automated manner on the DNA synthesizer.
We have never found conditions which allow the TFA group to be removed from an amino-modifier while the oligonucleotide remains attached to the support. We are able to solve this problem by using a 9-fluorenylmethoxycarbonyl (Fmoc) protecting group. The Fmoc group is removed using a two step procedure, the first to remove the cyanoethyl protection groups and flush the formed acrylonitrile from the synthesis column using 1% diisopropylamine in acetonitrile, and the second to remove the Fmoc group using 10% piperidine in DMF. The amino group so formed on the column can be reacted with a variety of activated esters.
We offer Fmoc-Amino-Modifier C6 dT Phosphoramidite as a nucleosidic option and Amino-Modifier Serinol Phosphoramidite as a non-nucleosidic alternative.
| 10-1535-90 |
100 µmole |
210.00 |
| 10-1535-02 |
0.25g | 550.00 |
| 10-1536-90 |
100 µmole |
180.00 |
|
10-1536-02 |
0.25g |
360.00 |
| 10-1997-95 | 50 µmole | 125.00 |
| 10-1997-90 | 100 µmole | 225.00 |
| 10-1997-02 | 0.25g | 595.00 |
|
3’-MODIFIERS
3’-Amino-Modifier CPGs, containing amino groups protected
with the base-labile Fmoc group, are designed to functionalize the 3’-terminus
of the target oligonucleotide by the introduction of a primary amine.
In an alternative approach, the nitrogen destined to become the 3’-amino
group is included in a phthalimide (PT) group which is attached to the
support through an amide group attached to the aromatic ring. This simple
linkage is very stable to all conditions of oligonucleotide synthesis
and contains no chiral center. Using an extended ammonium hydroxide treatment
(55°C for 17 hours), the cleavage of the amine from the phthalimide
is accomplished along with the deprotection of the oligonucleotide. ABI-style
columns are supplied unless otherwise requested.
| 20-2957-01 | 0.1g | 95.00 |
| 20-2957-10 | 1.0g | 675.00 |
| 1 µmole columns | 20-2957-41 | Pack of 4 | 140.00 |
| 0.2 µmole columns | 20-2957-42 | Pack of 4 | 85.00 |
| 10 µmole column (ABI) |
20-2957-13 | Pack of 1 | 250.00 |
| 15 µmole column (Expedite) |
20-2957-14 | Pack of 1 | 375.00 |
| 20-2958-01 | 0.1g | 95.00 |
| 20-2958-10 | 1.0g | 675.00 |
| 1 µmole columns | 20-2958-41 | Pack of 4 | 140.00 |
| 0.2 µmole columns | 20-2958-42 | Pack of 4 | 85.00 |
| 10 µmole column (ABI) |
20-2958-13 | Pack of 1 | 250.00 |
| 15 µmole column (Expedite) |
20-2958-14 | Pack of 1 | 375.00 |
| 20-2997-01 | 0.1g | 95.00 |
| 20-2997-10 | 1.0g | 675.00 |
| 0.2 µmole columns | 20-2997-42 | Pack of 4 | 85.00 |
| 1 µmole columns | 20-2997-41 | Pack of 4 | 140.00 |
| 10 µmole column (ABI) | 20-2997-13 | Pack of 1 | 250.00 |
15 µmole column (Expedite) | 20-2997-14 | Pack of 1 | 375.00 |
| 20-2954-01 | 0.1g | 95.00 |
| 20-2954-10 | 1.0g | 675.00 |
| 1 µmole columns | 20-2954-41 | Pack of 4 | 140.00 |
| 0.2 µmole columns | 20-2954-42 | Pack of 4 | 85.00 |
| 10 µmole column (ABI) | 20-2954-13 | Pack of 1 | 250.00 |
| 15 µmole column (Expedite) |
20-2954-14 | Pack of 1 | 375.00 |
| 20-2956-01 | 0.1g | 95.00 |
| 20-2956-10 | 1.0g | 675.00 |
| 1 µmole columns | 20-2956-41 | Pack of 4 | 140.00 |
| 0.2 µmole columns | 20-2956-42 | Pack of 4 | 85.00 |
| 10 µmole column (ABI) |
20-2956-13 | Pack of 1 | 250.00 |
| 15 µmole column (Expedite) |
20-2956-14 | Pack of 1 | 375.00 |
| 200 nmole columns (ABI 3900) | 26-2956-52 | Pack of 10 | 220.00 |
| 40 nmole columns (ABI 3900) | 26-2956-55 | Pack of 10 | 220.00 |
The 3’-Thiol-Modifier S-S CPG supports are used to introduce 3’-thiol linkages with three and six carbon spacers in oligonucleotides. DTPA CPG is used to introduce a dithiol group at the 3’-terminus. In conjunction with DTPA Phosphoramidite, it is simple to produce oligonucleotides with multiple thiol groups at the 3’ terminus, which is ideal for conjugation to gold surfaces. With Glyceryl CPG the 3’-terminus of an oligonucleotide is readily oxidized by sodium periodate to form a 3’-phosphoglycaldehyde. The aldehyde may be further oxidized to the corresponding carboxylic acid. Either the aldehyde or the carboxylate may be used for subsequent conjugation to amine-containing products.
| 20-2933-01 | 0.1g | 85.00 |
| 20-2933-10 | 1.0g | 600.00 |
| 1 µmole columns | 20-2933-41 | Pack of 4 | 125.00 |
| 0.2 µmole columns | 20-2933-42 | Pack of 4 | 75.00 |
| 10 µmole column (ABI) | 20-2933-13 | Pack of 1 | 225.00 |
| 15 µmole column (Expedite) | 20-2933-14 | Pack of 1 | 350.00 |
| 20-2936-01 | 0.1g | 85.00 |
| 20-2936-10 | 1.0g | 600.00 |
| 1 µmole columns | 20-2936-41 | Pack of 4 | 125.00 |
| 0.2 µmole columns | 20-2936-42 | Pack of 4 | 75.00 |
| 10 µmole column (ABI) | 20-2936-13 | Pack of 1 | 225.00 |
| 15 µmole column (Expedite) | 20-2936-14 | Pack of 1 | 350.00 |
| 20-2937-01 | 0.1g | 125.00 |
| 20-2937-10 | 1.0g | 895.00 |
| 1 µmole columns | 20-2937-41 | Pack of 4 | 185.00 |
| 0.2 µmole columns | 20-2937-42 | Pack of 4 | 110.00 |
| 10 µmole column (ABI) | 20-2937-13 | Pack of 1 | 335.00 |
| 15 µmole column (Expedite) | 20-2937-14 | Pack of 1 | 520.00 |
| 20-2902-01 | 0.1g | 85.00 |
| 20-2902-10 | 1.0g | 600.00 |
| 1 µmole columns | 20-2902-41 | Pack of 4 | 125.00 |
| 0.2 µmole columns | 20-2902-42 | Pack of 4 | 75.00 |
| 10 µmole column (ABI) | 20-2902-13 | Pack of 1 | 225.00 |
| 15 µmole column (Expedite) | 20-2902-14 | Pack of 1 | 350.00 |
| 20-2019-01 | 0.1g | 120.00 |
| 20-2019-10 | 1.0g | 995.00 |
| 1 µmole columns | 20-2019-41 | Pack of 4 | 200.00 |
| 0.2 µmole columns | 20-2019-42 | Pack of 4 | 120.00 |
| 10 µmole column (ABI) | 20-2019-13 | Pack of 1 | 300.00 |
| 15 µmole column (Expedite) | 20-2019-14 | Pack of 1 | 450.00 |
| 20-2039-01 | 0.1g | 96.00 |
| 20-2039-10 | 1.0g | 800.00 |
| 1 µmole columns | 20-2039-41 | Pack of 4 | 160.00 |
| 0.2 µmole columns | 20-2039-42 | Pack of 4 | 96.00 |
| 10 µmole column (ABI) | 20-2039-13 | Pack of 1 | 240.00 |
| 15 µmole column (Expedite) | 20-2039-14 | Pack of 1 | 360.00 |
|
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
|
Please inquire for availability
of columns for other
instrument types.
|
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
|
Please inquire for availability
of columns for other
instrument types.
|
|
CHEMICAL
PHOSPHORYLATION
Chemical Phosphorylation Reagent is most commonly used to
phosphorylate the 5’-terminus of an oligonucleotide. Although this
product is also successful in 3’-phosphorylation, 3’-Phosphate
CPG allows direct preparation of oligonucleotides with a 3’-phosphate
group. Chemical Phosphorylation Reagent II contains a DMT group on a side
chain which is stable to base cleavage and can be left on the oligonucleotide
for use in RP purification. The DMT group is later removed with aqueous
acid and the side chain is eliminated after brief treatment with aqueous
ammonium hydroxide to yield the 5’-phosphate.1 ABI-style vials and
columns are supplied unless otherwise requested.
| 10-1900-90 | 100 µmole | 50.00 |
| 10-1900-02 | 0.25g | 160.00 |
| 20-2900-01 | 0.1g | 70.00 |
| 20-2900-10 | 1.0g | 480.00 |
| 1 µmole columns | 20-2900-41 | Pack of 4 | 100.00 |
| 0.2 µmole columns | 20-2900-42 | Pack of 4 | 60.00 |
| 10 µmole column (ABI) | 20-2900-13 | Pack of 1 | 180.00 |
| 15 µmole column (Expedite) | 20-2900-14 | Pack of 1 | 280.00 |
| 200 nmole columns (ABI 3900) | 26-2900-52 | Pack of 10 | 150.00 |
| 40 nmole columns (ABI 3900) | 26-2900-55 | Pack of 10 | 150.00 |
| 25-2900-01 | 0.1g | 85.00 |
| 25-2900-10 | 1.0g | 600.00 |
| 2.5 µmole columns | 25-2900-46 | Pack of 4 | 120.00 |
| 10-1901-90 | 100 µmole | 60.00 |
| (CPR II) | 10-1901-02 | 0.25g | 200.00 |
| 10-1902-90 |
100 µmole | 60.00 |
| (Solid CPR II) |
10-1902-02 |
0.25g | 200.00 |
|
INTELLECTUAL PROPERTY
Chemical Phosphorylation Reagent is provided
under license from Bayer Corporation.
Chemical Phosphorylation Reagent II is covered by US Patent No.: 5,959,090.
REFERENCE
(1) A. Guzaev, H.Salo, A. Azhayev, and H. Lonnberg, Tetrahedron, 1995,
51, 9375-9384.
SEE ALSO
High load
supports p30
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
|
Please inquire for availability
of columns for other
instrument types.
|
|
ALDEHYDE MODIFICATION
Aldehyde modifiers would be attractive electrophilic substitutions in oligonucleotides since they are able to react with amino groups to form a Schiff’s base, with hydrazino groups to form hydrazones, and with semicarbazides to form semi-carbazones. The Schiff’s base is unstable and must be reduced with sodium borohydride to form a stable linkage but hydrazones and semicarbazides are very stable linkages.
Our collaboration with Epoch Biosciences, a subsidiary of Nanogen, Inc., has allowed us to offer 5'-Aldehyde-Modifier C2 Phosphoramidite. The acetal protecting group is sufficiently hydrophobic for use in RP HPLC and cartridge purification and is readily removed after oligonucleotide synthesis under standard oligonucleotide detritylation conditions with 80% acetic acid / 20% water or 2% aqueous trifluoroacetic acid during cartridge purification.
A formylindole nucleoside analogue has been used to introduce aldehyde groups within an oligonucleotide or at the 5’ terminus. This product has no protecting group on the aldehyde, which means that deprotection of the modified oligonucleotide can be done without changing preferred conditions.
| 10-1933-90 | 100 µmole | 85.00 |
| 10-1933-02 | 0.25g | 325.00 |
| 10-1934-90 |
100 µmole | 85.00 |
|
10-1934-02 |
0.25g | 325.00 |
|
INTELLECTUAL PROPERTY
These Products are for research purposes only, and may not be used for commercial, clinical, diagnostic or any other use. The Products are subject to proprietary rights of Epoch Biosciences, Inc. and are made and sold under license from Epoch Biosciences, Inc. There is no implied license for commercial use with respect to the Products and a license must be obtained directly from Epoch Biosciences, Inc. with respect to any proposed commercial use of the Products. “Commercial use” includes but is not limited to the sale, lease, license or other transfer of the Products or any material derived or produced from them, the sale, lease, license or other grant of rights to use the Products or any material derived or produced from them, or the use of the Products to perform services for a fee for third parties (including contract research).
A simple agreement must be signed before end-users and custom oligo services may purchase these products for use as defined above.
http://www.glenresearch.com/ Reference/EpochProducts.pdf
|
SPACER MODIFIERS
The spacer phosphoramidites C3, 9, C12 and 18 are used to
insert a spacer arm in an oligonucleotide. The compounds may be added
in multiple additions when a longer spacer is required. 3’-Spacer
C3 CPG may also act as a blocker of exonuclease and polymerase activity
at the 3’-terminus. dSpacer is used to introduce a stable abasic
site within an oligonucleotide. PC Spacer is a photocleavable C3 spacer
modifier, part of our line of photocleavable (PC) modifiers
| 10-1909-90 | 100 µmole | 75.00 |
| 10-1909-02 | 0.25g | 240.00 |
| 10-1913-90 | 100 µmole | 75.00 |
| 10-1913-02 | 0.25g | 240.00 |
| 10-1914-90 | 100 µmole | 85.00 |
| 10-1914-02 | 0.25g | 295.00 |
| 10-1915-95 | 50 µmole | 190.00 |
| (PYR) |
10-1915-90 | 100 µmole | 380.00 |
| 10-1915-02 | 0.25g | 1085.00 |
| 10-1918-90 | 100 µmole | 95.00 |
| 10-1918-02 | 0.25g | 240.00 |
| 10-1928-90 | 100 µmole | 95.00 |
| 10-1928-02 | 0.25g | 240.00 |
| 20-2913-01 | 0.1g | 70.00 |
| 20-2913-10 | 1.0g | 480.00 |
| 1 µmole columns | 20-2913-41 | Pack of 4 | 100.00 |
| 0.2 µmole columns | 20-2913-42 | Pack of 4 | 60.00 |
| 10 µmole column (ABI) | 20-2913-13 | Pack of 1 | 180.00 |
| 15 µmole column (Expedite) | 20-2913-14 | Pack of 1 | 280.00 |
| 10-4913-90 | 100 µmole | 135.00 |
| 10-4913-02 | 0.25g | 395.00 |
|
ALSO SEE
PC Modifiers p74
Pyrrolidine p56
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
|
Please inquire for availability
of columns for other
instrument types.
|
|
Dendrimers
Dendrimers are discrete, highly branched, monodispersed polymers that possess patterns reminiscent of the branching of trees. Plain and mixed oligonucleotide dendrimers can be synthesized using novel doubling and trebling phosphoramidite synthons.1,2 Dendrimers offer the following advantages. Incorporation of label using γ-32P-ATP and polynucleotide kinase increases in proportion to the number of 5’-ends. Fluorescent signal also increases in proportion to the number of 5’-ends, if spacers are incorporated between the labels and the ends of the branches. When using a dendrimeric oligonucleotide as a PCR primer, the strand bearing the dendrimer is resistant to degradation by T7 Gene 6 exonuclease making it easy to convert the double-stranded product of the PCR to a multiply labelled, single-stranded probe. Enhanced stability of DNA dendrimers makes them useful as building blocks for the ‘bottom up’ approach to nano-assembly. These features also suggest applications in DNA chip technology when higher temperatures are required, for example, to melt secondary structure in the target.
| 10-1920-90 | 100 µmole | 150.00 |
| 10-1920-02 | 0.25g | 240.00 |
| 10-1921-90 | 100 µmole | 180.00 |
| 10-1921-02 | 0.25g | 300.00 |
| 10-1922-90 | 100 µmole | 180.00 |
| 10-1922-02 | 0.25g | 300.00 |
| 10-1925-90 | 100 µmole | 200.00 |
| 10-1925-02 | 0.25g | 300.00 |
|
REFERENCES
(1) M.S. Shchepinov, I.A. Udalova, A.J. Bridgman, and
E.M. Southern, Nucleic Acids Res, 1997, 25, 4447-4454.
(2) M.S. Shchepinov, K.U. Mir, J.K. Elder, M.D. Frank-Kamenetskii, and
E.M. Southern, Nucleic Acids Res, 1999, 27, 3035-41.
(3) T. Horn, C.A. Chang, and M.S. Urdea, Nucleic Acids Res, 1997, 25,
4842-4849.
INTELLECTUAL PROPERTY
Doublers and Trebler are supplied under license from ISIS Innovation Limited.
5-Me-dC Brancher Phosphoramidite is provided under license from Siemens Corporation.
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
|
BRANCHING PHOSPHORAMIDITE
A branching monomer is required to construct comb-like oligonucleotide
probes. The developers of the comb system from Chiron Corporation evaluated3
several protecting groups for the branch point and chose levulinyl (LEV),
which is specifically removed using a reagent containing hydrazine hydrate,
acetic acid and pyridine.
| 10-1018-90 | 100 µmole | 205.00 |
| 10-1018-02 | 0.25g | 505.00 |
|
Photocleavable Monomers
PC Biotin Phosphoramidite can be used to prepare 5’-biotinylated
oligonucleotides suitable for capture by streptavidin in a mode similar
to our popular 5’ Biotin Phosphoramidite. Amino- and thiol-modified
oligonucleotides have proven to be very useful for the attachment of a
variety of haptens and fluorophores, as well as for the tethering of the
oligonucleotides to a diversity of beads and surfaces. PC Amino-Modifier
Phosphoramidite is used to prepare 5’-amino-modified oligonucleotides
suitable for subsequent photocleavage. PC Spacer Phosphoramidite can be
used as an intermediary to attach any modification reagent, available
as a phosphoramidite, to the terminus of oligonucleotides. After photocleavage,
a 5’-phosphate is generated on the DNA, rendering it suitable for
further biological transformations, such as gene construction and cloning
after ligation.
A versatile photocleavable DNA building block has been described by researchers
in Washington University, Missouri and used in phototriggered hybridization.1
This reagent has also been used in the design of multifunctional DNA and
RNA conjugates2 for the in vitro selection of new molecules catalyzing
biomolecular reactions. Researchers at Bruker Daltonik in Germany have
also developed genoSNIP, a method for single-nucleotide polymorphism (SNP)
genotyping by MALDI-TOF mass spectrometry.3 This method uses size reduction
of primer extension products by incorporation of the photocleavable linker
for phototriggering strand breaks near to the 3' end of the extension
primer. PC Linker can be incorporated into oligonucleotides at any position
by standard automated DNA synthesis methodology. PC Linker Phosphoramidite
has the added advantage in that photocleavage results in monophosphate
fragments at both the 3'- and 5'-termini of the oligonucleotide
fragments.
| 10-4950-95 |
50 µmole |
135.00 |
|
10-4950-90 |
100 µmole |
250.00 |
|
10-4950-02 |
0.25g |
675.00 |
| 10-4906-90 |
100 µmole |
135.00 |
|
10-4906-02 |
0.25g |
395.00 |
| 10-4913-90 |
100 µmole |
135.00 |
|
10-4913-02 |
0.25g |
395.00 |
| 10-4920-90 |
100 µmole |
255.00 |
|
10-4920-02 |
0.25g |
795.00 |
|
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
INTELLECTUAL PROPERTY
Glen Research offers PC Biotin, PC Amino-Modifier and PC Spacer products
in association with AmberGen, Inc. and Link Technologies, Ltd. For a commercial
application license, please contact AmberGen, Inc., +617-975-0680, http://www.ambergen.com.
PC Linker phosphoramidite is available from Glen Research In association
with Link Technologies Ltd (Scotland).
SEE ALSO
5’-Biotin Phosphoramidite p75
References
(1) P. Ordoukhanian and J-S. Taylor, J. Am. Chem. Soc., 117, 9570-9571, 1995.
(2a) F. Hausch and A. Jäschke, Nucleic Acids Research, 2000, 28, e35.
(2b) F. Hausch and A. Jäschke, Tetrahedron, 2001, 57, 1261-1268.
(3) T. Wenzel, T. Elssner, K. Fahr, J. Bimmler, S. Richter, I. Thomas, and M. Kostrzewa, Nucleosides, Nucleotides & Nucleic Acids, 2003, 22, 1579-1581.
|
OLIGONUCLEOTIDE-PEPTIDE CONJUGATES
The OPeC™ method for the synthesis of Oligonucleotide-Peptide Conjugates, originally described by Stetsenko and Gait1,2, is based on the “native ligation” of an N-terminal thioester-functionalized peptide to a 5’-cysteinyl oligonucleotide. OPeC™reagents have been developed by Link Technologies Ltd. In OPeC™ conjugation strategies, peptide and oligonucleotide units are easily assembled separately on their own supports using conventional synthesizers and methodology. Each biomolecule is designed to carry a reactive functionality that is released upon full deprotection and cleavage from the support. The components can then be conjugated in aqueous/organic solution by selective reaction of these functionalities.
| 50-1000-01 | each | 495.00 |
Each OPeC kit consists of the
following components, which can also be ordered individually as
shown: |
| 50-1001-01 | 150µmole | 290.00 |
| 50-1002-01 | 450µmole | 250.00 |
| 50-1003-01 | 230mg | 75.00 |
Conjugation using Click Chemistry
The conjugation reaction between azides and alkynes to form 1,2,3-triazoles, as reported3 by Sharpless, was found to be so exquisitely regioselective and efficient at even the most mild conditions that Sharpless coined the term ‘Click Chemistry’ to describe it. Oligonucleotides prepared using 5’-Hexynyl Phosphoramidite are stable to standard deprotection conditions and exhibit a slightly increased retention time on RP HPLC. A number of azide labels are commercially available for click conjugation to a 5’-hexynyl-modified oligonucleotide. Azides are not compatible with oligonucleotide synthesis using phosphoramidites so a post-synthesis reaction is likely to be required. We found we were able to quantitatively convert a 5’-iodo-modified oligonucleotide (prepared using 5’-Iodo-dT) to the corresponding 5’-azide.
| 10-1908-90 |
100 µmole |
60.00 |
|
10-1908-02 |
0.25g |
200.00 |
| 10-1931-90 |
100 µmole |
85.00 |
|
10-1931-02 |
0.25g |
295.00 |
| 50-1904-23 |
2.3mg |
60.00 |
| (Dissolve 2.3mg in 60µL of DMSO) |
50-1904-24 |
23mg |
300.00 |
| 10-1946-90 |
100 µmole |
60.00 |
|
10-1946-02 |
0.25g |
200.00 |
|
INTELLECTUAL
PROPERTY
OPeC™ reagents for research use are licensed under Patent No. PCT/GB00/03306
from the Medical Research Council, London, UK. These reagents are for
research use only. A license for the commercial use of these products
must be obtained from Medical Research Council Technology, 20 Park Crescent,
London W1N 4AL, UK.
References
(1) D.A. Stetsenko and M.J. Gait, J Org Chem, 2000, 65, 4900-4908.
(2) D.A. Stetsenko and M.J. Gait, Nucleos Nucleot Nucleic Acids, 2000,
19, 1751-1764.
(3) V.V. Rostovtsev, Green, L.G., Fokin, V.V. and Sharpless, K.B., Angew Chem Int Ed, 2002, 41, 2596-2599.
STABILITY NOTES
Oligonucleotides containing a 5’-iodo group are prepared conventionally with the exception that deprotection is carried out in ammonium hydroxide at room temperature for 24 hours. Under these conditions, degradation of the iodo group was less than 2%.
OPeC is a trademark of www.linktech.co.uk |
http://www.glenres.com/Catalog/modifiers.html
|
|